Abstract:Background: In recent years, tissue engineered bone by gene-modified stem cells compounded with scaffold materials in repair of bone defect has provided a novel thought for the bone tissue reconstruction. Objective: To explore the effect on repairing mandibular defect with human bone morphogenetic protein-2 (hBMP-2) gene transfected bone marrow mesenchymal stem cells (BMSCs) compounded with coral hydroxyapatite (CHA) scaffolds in osteoporotic rats. Design, time and setting: A randomized control animal experiment was completed at the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education from June 2005 to October 2006. Materials: Twenty-four unpregnant female Sprague-Dawley rats, 6 months old, SPF gradem weighing 250-300 g, were used to establish models of postmenopausal osteoporosis, The pcDNA3.1-hBMP-2 recombinant plasmid carrying hBMP-2 was offered by the Third Military Medical University of Chinese PLA; CHA scaffolds was offered by the Key Laboratory for Oral Biomedical Engineering by the State Ministry of Education. Methods: Twenty-four SD rats were divided into experimental group and control group at random, each containing 12 animals. Three months later, BMSCs harvested from osteoporotic rats were transfected by pcDNA3.1-hBMP-2 recombinant plasmid, and control group leaved untreated. Three days later, the transfected and untransfected autogenous BMSCs were seeded into CHA scaffolds, respectively. Then the cell/scaffolds composites were implanted into the critical-size defect area in the mandible bone of osteoporotic rats. Main outcome measures: At the 4th and 8th weeks after implantation, immunohistochemical analysis was performed to evaluate the new bone formation, and the amount of newly formed bone was detected semi-quantitatively at the 8th weeks. Results: All 24 SD rats were involved in the result analysis. 1 Newly formed bone was found at the margin of the defect area treated with the BMSCs modified by BMP-2 gene transfer at 4 weeks after implantation. The lamellar bone matrix was visible at 8 weeks. In the control group, only a little bone matrix was observed at the margin of CHA material at 4 weeks after implantation, however, the amount of newly formed bone was much less than the experimental group, and there was some adipose-like tissues at defect margins and central part at 8 weeks after implantation. 2 The percentage of newly formed bone area was (0.046±0.004)% and (0.233±0.015)% in the control group and the experimental group, respectively. There were significant differences in the amount of newly formed bone between two groups (P < 0.01). Conclusion: Tissue engineered bone formed by hBMP-2 gene-modified BMSCs in conjunction with CHA scaffolds, can allow large bone formation for treatment of mandibular defect in osteoporosis rats.

hVEGF Gene Modified Tissue-engineered Compound in the Reconstruction of Periodontal Tissue Defects in SD Rats

Potential of an Aligned Porous Hydrogel Scaffold Combined with Periodontal Ligament Stem Cells or Gingival Mesenchymal Stem Cells to Promote Tissue Regeneration in Rat Periodontal Defects

Effect of Hbmp-7 Gene Modified Bone Marrow Stromal Cells on Periodontal Tissue Regeneration

hBMP-7 Gene Modified Bone Marrow Stromal Cells on the Effects of Healing of Periodontal Furcation Defects in Osteoporosis Rats

The Complex Constructed by hVEGF165 Genes Transfected BMSCs and Collagen Membrane (BME-10X) Enhanced Osteogenesis and Angiogenesis

Effects of the hbFGF and hBMP-7 gene-modified tissue-engineered complex on the regeneration of alveolar bone defects:an animal study

Enhanced Repair of Segmental Bone Defects of Rats with Hvegf-165 Gene-Modified Endothelial Progenitor Cells Seeded in Nanohydroxyapatite/collagen/poly(l-Lactic Acid) Scaffolds

VEGF Gene Transfected Human BMSCs Acting as Seeding Cell for Tissue Engineering Bond in Orbital Wall Bone Defects

Research on Promoting Periodontal Regeneration with Human Basic Fibroblast Growth Factor-Modified Bone Marrow Mesenchymal Stromal Cell Gene Therapy

Experimental Study of Construction of Tissue Engineered Bone by Porous CPC with Bone Mesenchymal Stem Cells Transfected with VEGF Gene for Repair of Rat Skull Defect

Combination of Î²-TCP and BMP-2 gene-modified bMSCs to heal critical size mandibular defects in rats: Mandibular repair by TCP & BMP2 gene-modified bMSCs

Repairing mandibular defect by gene-modified bone marrow mesenchymal stem cells combined with coral hydroxyapatite scaffold in osteoporotic rats

An investigation of restoration of cleft alveolar with vascularised engineered bone

Transfect Bone Marrow Stromal Cells with Pcdna3.1-Vegf to Construct Tissue Engineered Bone in Defect Repair

Effects of Bone Marrow Stromal Cells with Different Seeding Densities on Periodontal Defect Repair in Sprague Dawley Rats

Combination of EMPs and BMSCs in promoting regeneration of periodontal tissue

A Study on the Repair of Canine Experimental Class n Furcation Defects by Bone Marrow Stromal Cells with Different Seeding Density

Tissue Engineering Bone and Bio-Oss in the Restoration of a Mandibular Critical Size Defects in Rats

Angiogenesis and Osteogenesis Enhanced by Bfgf Ex Vivo Gene Therapy for Bone Tissue Engineering in Reconstruction of Calvarial Defects.

A study of basic fibroblast growth factor gene modified tissue-engineered compound on the healing of gingiva defects

In Vivo Alveolar Bone Regeneration by Bone Marrow Stem Cells/Fibrin Glue Composition